Team:Arizona State
From 2013.igem.org
(Difference between revisions)
Line 39: | Line 39: | ||
<center><div class="fb-like" data-href="https://www.facebook.com/pages/ASU-iGEM/196387053746045?fref=ts" data-send="true" data-width="450" data-show-faces="false"></div></center> | <center><div class="fb-like" data-href="https://www.facebook.com/pages/ASU-iGEM/196387053746045?fref=ts" data-send="true" data-width="450" data-show-faces="false"></div></center> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
</body> | </body> | ||
</html> | </html> |
Revision as of 16:07, 5 September 2013
Home | Team | Official Team Profile | Project | Parts Submitted to the Registry | Modeling | Notebook | Safety | Attributions |
---|
Cancer kills eight million people each year. Current treatments involve therapies such as chemotherapy and radiation that cannot differentiate between cancerous and healthy tissue. The ASU iGEM team proposes a novel vaccine delivery system of tumor-specific proteins and other elements to mitigate the anti-immune response of tumor cells, all encapsulated within probiotic bacteria, akin to those found in commercial yogurt. The vaccine should activate immune cells to teach a patient’s immune system to detect specific markers that distinguish tumors from healthy tissue and destroy the tumor cells.